Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
The closing price of IO Biotech Inc (NASDAQ: IOBT) was $0.87 for the day, down -2.93% from the previous closing price of $0.9. In other words, the price has decreased by -$2.93 from its previous closing price. On the day, 1.21 million shares were traded. IOBT stock price reached its highest trading level at $0.9 during the session, while it also had its lowest trading level at $0.834.
Ratios:
Our analysis of IOBT’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 1.96 and its Current Ratio is at 1.96. In the meantime, Its Debt-to-Equity ratio is 5.26 whereas as Long-Term Debt/Eq ratio is at 4.77.
On September 30, 2025, Morgan Stanley Downgraded its rating to Equal-Weight which previously was Overweight but kept the price unchanged to $0.39.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on May 30 ’25 when Hunter Heidi bought 15,000 shares for $1.39 per share. The transaction valued at 20,884 led to the insider holds 15,000 shares of the business.
Ahmad Qasim Iftikhar bought 31,350 shares of IOBT for $26,553 on Dec 23 ’24. The Chief Medical Officer now owns 31,350 shares after completing the transaction at $0.85 per share. On Dec 23 ’24, another insider, Zocca Mai-Britt, who serves as the Chief Executive Officer of the company, bought 12,500 shares for $0.81 each. As a result, the insider paid 10,120 and bolstered with 49,891 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, IOBT now has a Market Capitalization of 57619444 and an Enterprise Value of 37844448.
Stock Price History:
The Beta on a monthly basis for IOBT is 0.52, which has changed by -0.29435486 over the last 52 weeks, in comparison to a change of 0.20772064 over the same period for the S&P500. Over the past 52 weeks, IOBT has reached a high of $2.79, while it has fallen to a 52-week low of $0.32. The 50-Day Moving Average of the stock is -29.51%, while the 200-Day Moving Average is calculated to be -29.06%.
Shares Statistics:
IOBT traded an average of 6.03M shares per day over the past three months and 10243140 shares per day over the past ten days. A total of 65.88M shares are outstanding, with a floating share count of 49.27M. Insiders hold about 25.21% of the company’s shares, while institutions hold 41.38% stake in the company. Shares short for IOBT as of 1760486400 were 1138820 with a Short Ratio of 0.19, compared to 1757894400 on 1067607. Therefore, it implies a Short% of Shares Outstanding of 1138820 and a Short% of Float of 3.61.
Earnings Estimates
The dynamic stock of IO Biotech Inc (IOBT) is currently attracting attention from 1.0 analysts actively involved in rating its market status.The consensus estimate for the next quarter is -$0.14, with high estimates of -$0.14 and low estimates of -$0.14.
Analysts are recommending an EPS of between -$0.94 and -$0.94 for the fiscal current year, implying an average EPS of -$0.94. EPS for the following year is -$0.57, with 1.0 analysts recommending between -$0.57 and -$0.57.
